| Entero Therapeutics, Inc. (ENTO) |
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 |
| Balance Sheet Date | | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | | | | | | | | | | | |
| Fiscal Period | | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | | | | | | | | | | | |
| Close Price of Common Stock | 2.51$ | 5.02$ | 0.38$ | 0.48$ | 0.65$ | 0.34$ | 1.28$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Market Cap of Common Stock | 8,438,377$ | 23,923,960$ | 1,810,977$ | 2,291,442$ | 3,085,365$ | 844,006$ | 3,168,115$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | (64.73%) | 1,221.05% | (20.97%) | (25.73%) | 265.56% | (73.36%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | 173.50% | 2,734.57% | (42.84%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Warrant | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Unit | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Right | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Shares Outstanding | 3,361,903 | 2,547,147 | 4,765,729 | 4,765,729 | 1,584,650 | 4,741,964 | 2,941,108 | 2,025,208 | 1,560,998 | 13,463,479 | 4,208,995 | 1,549,581 | 49,750 | 2,307,008 | 22,699,812 | 21,548,835 | 70,742 | 11,115,228 | 82,585,075 | 74,926,902 | 3,115,030 | 28,881,984 | 28,502,850 | 27,157,651 | 26,800,519 | 28,881,984 | 21,103,434 | 18,537,958 | 17,704,925 | 16,940,462 | 16,792,395 | 12,602,395 | 12,042,574 | 11,421,702 | 11,118,160 | 9,631,088 | 9,631,088 | 6,028,928 | 5,999,978 | 4,725,879 | 4,296,979 | 3,587,455 | | | | | | | |
| QoQ% | 31.99% | (46.55%) | .00% | 200.74% | (66.58%) | 61.23% | 45.23% | 29.74% | (88.41%) | 219.87% | 171.62% | 3,014.74% | (97.84%) | (89.84%) | 5.34% | 30,361.16% | (99.36%) | (86.54%) | 10.22% | 2,305.34% | (89.22%) | 1.33% | 4.95% | 1.33% | (7.21%) | 36.86% | 13.84% | 4.71% | 4.51% | .88% | 33.25% | 4.65% | 5.44% | 2.73% | 15.44% | .00% | 59.75% | .48% | 26.96% | 9.98% | 19.78% | | | | | | | | |
| YoY% | 112.15% | (46.29%) | 62.04% | 135.32% | 1.52% | (64.78%) | (30.12%) | 30.69% | 3,037.68% | 483.59% | (81.46%) | (92.81%) | (29.67%) | (79.25%) | (72.51%) | (71.24%) | (97.73%) | (61.52%) | 189.74% | 175.90% | (88.38%) | .00% | 35.06% | 46.50% | 51.37% | 70.49% | 25.67% | 47.10% | 47.02% | 48.32% | 51.04% | 30.85% | 25.04% | 89.45% | 85.30% | 103.80% | 124.14% | 68.06% | | | | | | | | | | | |